Senior insider sale
Chief Scientific Officer at NUVATION BIO INC. — senior position signals high conviction
$3.17M
469.05K shares
What this filing means
HATTERSLEY GARY plans to sell 469.05K shares of NUVATION BIO INC. valued at approximately $3.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/20/2025ACC: 0001950047-25-009134
Officer· Chief Scientific Officer
Since Feb 2021
469.05K
Shares to sell
$3.17M
Approx. market value
369.05K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Exercise of options under a registered plan
Cash
11/20/2025
69.05KExercise of options under a registered plan
Cash
11/20/2025
300KTotal acquired369.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/20/2025 | Exercise of options under a registered plan Cash | 69.05K | — |
11/20/2025 | Exercise of options under a registered plan Cash | 300K | — |
| Total | 369.05K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
100K
Market value
$502.5K
10/27/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
369.05K
Market value
$2.67M
11/20/2025
Total
Units
469.05K
Value
$3.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/27/2025 | 100K | $502.5K | — | Completed |
| Planned — Approximate Date | ||||
11/20/2025 | 369.05K | $2.67M | NYSE | Planned |
| Total | 469.05K | $3.17M | ||